New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
出版年份 2021 全文链接
标题
New approved and emerging pharmacological approaches to alcohol use disorder: a review of clinical studies
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume -, Issue -, Pages 1-13
出版商
Informa UK Limited
发表日期
2021-02-22
DOI
10.1080/14656566.2021.1892641
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acetylcholine muscarinic M4 receptors as a therapeutic target for alcohol use disorder: Converging evidence from humans and rodents
- (2020) Leigh C. Walker et al. BIOLOGICAL PSYCHIATRY
- Therapy resistance/chronicity, their determinants and potential solutions
- (2020) Hans-Jürgen Möller EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms
- (2020) Raymond F. Anton et al. JAMA Internal Medicine
- Potential of GABAB Receptor Positive Allosteric Modulators in the Treatment of Alcohol Use Disorder
- (2019) Paola Maccioni et al. CNS DRUGS
- Oxytocin attenuates stress-induced reinstatement of alcohol seeking behavior in male and female mice
- (2019) Courtney E. King et al. PSYCHOPHARMACOLOGY
- Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats
- (2019) Saeideh Karimi-Haghighi et al. ADDICTION BIOLOGY
- A Meta‐analysis of the Efficacy of Gabapentin for Treating Alcohol Use Disorder
- (2019) Henry R. Kranzler et al. ADDICTION
- Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
- (2019) Mehdi Farokhnia et al. PHYSIOLOGY & BEHAVIOR
- Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala
- (2019) Brendan J. Tunstall et al. PLOS BIOLOGY
- Ketamine and depression: a narrative review
- (2019) Alexandrine Corriger et al. Drug Design Development and Therapy
- Advances in the science and treatment of alcohol use disorder
- (2019) K. Witkiewitz et al. Science Advances
- Brain N-Acetyl Aspartate and associations with cognitive impairment in alcohol dependent patients
- (2019) Kirsten C. Morley et al. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY
- Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice
- (2019) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
- (2019) Elias Dakwar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial
- (2019) Erin J. Campbell et al. BRAIN RESEARCH
- Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
- (2019) Sean P. Moran et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Baclofen for alcohol use disorder-a systematic meta-analysis
- (2018) T. Bschor et al. ACTA PSYCHIATRICA SCANDINAVICA
- Moderation of baclofen response by a GABAB receptor polymorphism: Results from the BacALD randomized controlled trial
- (2018) Kirsten C. Morley et al. ADDICTION
- Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis
- (2018) Abigail K. Rose et al. ADDICTION
- Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial
- (2018) Kirsten C. Morley et al. BRITISH JOURNAL OF PSYCHIATRY
- Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis
- (2018) Mimi Pierce et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Rationale for N-acetyl cysteine in the treatment of alcohol use disorder in patients with liver disease.
- (2018) Kirsten C. Morley et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder
- (2018) Claire E. Wilcox et al. Journal of Addiction Medicine
- The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
- (2018) Mary R. Lee et al. MOLECULAR PSYCHIATRY
- Novel approaches to alcohol rehabilitation: Modification of stress-responsive brain regions through environmental enrichment
- (2018) Terence Y. Pang et al. NEUROPHARMACOLOGY
- Ketamine for the treatment of addiction: Evidence and potential mechanisms
- (2018) I. Ivan Ezquerra-Romano et al. NEUROPHARMACOLOGY
- Muscarinic M5 receptors modulate ethanol seeking in rats
- (2018) Alice E. Berizzi et al. NEUROPSYCHOPHARMACOLOGY
- Noradrenergic targets for the treatment of alcohol use disorder
- (2018) Carolina L. Haass-Koffler et al. PSYCHOPHARMACOLOGY
- A molecular mechanism for choosing alcohol over an alternative reward
- (2018) Eric Augier et al. SCIENCE
- Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking
- (2018) Stephanie S. O’Malley et al. JAMA Psychiatry
- Commonality of Ethanol and Nicotine Reinforcement and Relapse in Wistar-Derived UChB Rats: Inhibition by N -Acetylcysteine
- (2018) Maria Elena Quintanilla et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder
- (2018) Tracy L. Simpson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder
- (2018) Henry R. Kranzler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Max G Griswold et al. LANCET
- Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
- (2018) Kirsten C. Morley et al. Trials
- A Review of Baclofen Overdoses in Australia: Calls to a Poisons Information Centre and a Case Series
- (2018) Nazila Jamshidi et al. ALCOHOL AND ALCOHOLISM
- A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
- (2018) E. Sherwood Brown et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Double-slit photoelectron interference in strong-field ionization of the neon dimer
- (2018) Maksim Kunitski et al. Nature Communications
- The role of neuroimmune signaling in alcoholism
- (2017) Fulton T. Crews et al. NEUROPHARMACOLOGY
- Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
- (2017) Lara A Ray et al. NEUROPSYCHOPHARMACOLOGY
- Oxytocin Reduces Alcohol Cue-Reactivity in Alcohol-Dependent Rats and Humans
- (2017) Anita C Hansson et al. NEUROPSYCHOPHARMACOLOGY
- Metabotropic and ionotropic glutamate receptors as potential targets for the treatment of alcohol use disorder
- (2017) Sunil Goodwani et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effect of alcohol use disorder on oxytocin peptide and receptor mRNA expression in human brain: A post-mortem case-control study
- (2017) Mary R. Lee et al. PSYCHONEUROENDOCRINOLOGY
- Effects of varenicline on alcohol cue reactivity in heavy drinkers
- (2017) Walter Roberts et al. PSYCHOPHARMACOLOGY
- The link between inflammation, bugs, the intestine and the brain in alcohol dependence
- (2017) S Leclercq et al. Translational Psychiatry
- Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial
- (2017) David A. Katz et al. Brain and Behavior
- Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
- (2016) Niamh Fitzgerald et al. ADDICTION
- Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers
- (2016) David A. Katz et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Oxytocin for the treatment of drug and alcohol use disorders
- (2016) Mary R. Lee et al. BEHAVIOURAL PHARMACOLOGY
- Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date
- (2016) Mary R. Lee et al. CNS DRUGS
- National trends in alcohol pharmacotherapy: Findings from an Australian claims database
- (2016) Kirsten C. Morley et al. DRUG AND ALCOHOL DEPENDENCE
- Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy
- (2016) Karl Mann et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Nalmefene for the treatment of alcohol use disorders: recent data and clinical potential
- (2016) Michael Soyka EXPERT OPINION ON PHARMACOTHERAPY
- Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder
- (2016) Jennifer M. Mitchell et al. Journal of Addiction Medicine
- The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical Trials
- (2016) Zachary W. Adams et al. Journal of Studies on Alcohol and Drugs
- Region-specific roles of the corticotropin-releasing factor–urocortin system in stress
- (2016) Marloes J. A. G. Henckens et al. NATURE REVIEWS NEUROSCIENCE
- The CRF1 Antagonist Verucerfont in Anxious Alcohol-Dependent Women: Translation of Neuroendocrine, But not of Anti-Craving Effects
- (2016) Melanie L Schwandt et al. NEUROPSYCHOPHARMACOLOGY
- A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence
- (2016) Megan L Ryan et al. NEUROPSYCHOPHARMACOLOGY
- Baclofen blocks yohimbine-induced increases in ethanol-reinforced responding in rats
- (2016) Keith L. Williams et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Role of the α1blocker doxazosin in alcoholism: a proof-of-concept randomized controlled trial
- (2015) George A. Kenna et al. ADDICTION BIOLOGY
- Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo-Controlled Trial
- (2015) Andrea de Bejczy et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial
- (2015) Ismene L. Petrakis et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Gabapentin
- (2015) Tracey L. Mersfelder et al. ANNALS OF PHARMACOTHERAPY
- Topiramate in Alcohol Use Disorders: Review and Update
- (2015) Riccardo Guglielmo et al. CNS DRUGS
- Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation
- (2015) Benjamin Rolland et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta-Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials
- (2015) Clément Palpacuer et al. PLOS MEDICINE
- A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders
- (2014) Janet C. Blodgett et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Topiramate Treatment for Heavy Drinkers: Moderation by aGRIK1Polymorphism
- (2014) Henry R. Kranzler et al. AMERICAN JOURNAL OF PSYCHIATRY
- Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol’s reinforcing effects in male alcohol preferring (P) rats.
- (2014) Catherine F. Moore et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- Corticotropin releasing factor: A key role in the neurobiology of addiction
- (2014) Eric P. Zorrilla et al. FRONTIERS IN NEUROENDOCRINOLOGY
- GRIK1 Genotype moderates topiramate's effects on daily drinking level, expectations of alcohol's positive effects and desire to drink
- (2014) Henry R. Kranzler et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Corticotropin Releasing Hormone-1 (CRH1) Receptor Antagonist Pexacerfont in Alcohol Dependence: A Randomized Controlled Experimental Medicine Study
- (2014) Laura E Kwako et al. NEUROPSYCHOPHARMACOLOGY
- Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
- (2014) Marilyn D. Skinner et al. PLoS One
- Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
- (2014) Boadie W Dunlop et al. Trials
- Choline-containing phospholipids: relevance to brain functional pathways
- (2013) Seyed Khosrow Tayebati et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- A Double-Blind, Placebo-Controlled Trial Assessing the Efficacy of Varenicline Tartrate for Alcohol Dependence
- (2013) Raye Z. Litten et al. Journal of Addiction Medicine
- Intranasal Oxytocin Blocks Alcohol Withdrawal in Human Subjects
- (2012) Cort A. Pedersen et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients
- (2012) Lorenzo Leggio et al. CNS & Neurological Disorders-Drug Targets
- The Impact of Gabapentin Administration on Brain GABA and Glutamate Concentrations: A 7T 1H-MRS Study
- (2012) Kejia Cai et al. NEUROPSYCHOPHARMACOLOGY
- Prazosin Effects on Stress- and Cue-Induced Craving and Stress Response in Alcohol-Dependent Individuals: Preliminary Findings
- (2011) Helen C. Fox et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
- (2011) Andreas Meyer-Lindenberg et al. NATURE REVIEWS NEUROSCIENCE
- Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse
- (2011) Wendy J. Lynch et al. PSYCHOPHARMACOLOGY
- CDP-Choline as a Biological Supplement During Neurorecovery: A Focused Review
- (2011) Patricia M. Arenth et al. PM&R
- Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing
- (2010) Maree Teesson et al. ADDICTION
- A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
- (2010) Howard N. Bockbrader et al. CLINICAL PHARMACOKINETICS
- Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients
- (2010) Bankole A. Johnson et al. CURRENT PHARMACEUTICAL DESIGN
- Activation of 4* nAChRs is Necessary and Sufficient for Varenicline-Induced Reduction of Alcohol Consumption
- (2010) L. M. Hendrickson et al. JOURNAL OF NEUROSCIENCE
- Brain stress systems in the amygdala and addiction
- (2009) George F. Koob BRAIN RESEARCH
- Neurochemical Alterations in Methamphetamine-Dependent Patients Treated with Cytidine-5′-Diphosphate Choline: A Longitudinal Proton Magnetic Resonance Spectroscopy Study
- (2009) Sujung J Yoon et al. NEUROPSYCHOPHARMACOLOGY
- Requirement of central ghrelin signaling for alcohol reward
- (2009) E. Jerlhag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of topiramate treatment on ethanol consumption in rats
- (2009) Florence J. Breslin et al. PSYCHOPHARMACOLOGY
- Topiramate for Alcohol Dependence
- (2008) Christina L Olmsted et al. ANNALS OF PHARMACOTHERAPY
- Baclofen attenuates cue-induced reinstatement of alcohol-seeking behavior in Sardinian alcohol-preferring (sP) rats
- (2008) Paola Maccioni et al. DRUG AND ALCOHOL DEPENDENCE
- Enhanced Negative Emotion and Alcohol Craving and Altered Physiological Responses Following Stress and Cue Exposure in Alcohol Dependent Individuals
- (2008) Rajita Sinha et al. NEUROPSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More